NASDAQ STOCKHOLM WELCOMES ARCOMA TO FIRST NORTH


Stockholm, November 14, 2014 — Nasdaq  (Nasdaq: NDAQ) announces that the trading in Arcoma AB (shortname: ARCOMA) shares commenced today on First North at Nasdaq Stockholm. Arcoma belongs to the Healthcare sector and is the 39th company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.

Arcoma delivers world-class digital radiographic systems combining its Scandinavian heritage for excellence in design and engineering with advanced imaging technology. Arcoma has established global sales channels and the company’s products are sold through distributors and through large multinational clients. Today there are more than 2,000 of Arcoma's radiographic systems installed worldwide. For more information, visit www.arcoma-imix.com.    

“I would like to welcome all our new shareholders and at the same time express our gratitude for the trust in Arcoma that they have displayed by investing in our company,” said  Jonas Salomonson, CEO at Arcoma. “The process of becoming a public company has been very inspiring and I have enjoyed meeting all investors, seeing their great interest in our business and our products.”

“We welcome Arcoma to First North and to our family of Nasdaq-listed companies,” said Adam Kostyál, Senior Vice President and head of European listings at Nasdaq. “Arcoma will make a valuable addition to our healthcare  sector, and we look forward to supporting the company in its endavour as a publically traded company.”

Arcoma has appointed Sedermera Fondkommission as Certified Adviser.


About First North
First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
 

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets.  As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of over $8.8 trillion and more than 10,000 corporate clients. To learn more, visit www.nasdaq.com/ambition or www.nasdaqomx.com.

   

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq OMX Copenhagen A/S, Nasdaq OMX Helsinki Ltd., Nasdaq OMX Iceland hf., Nasdaq OMX Riga, AS, Nasdaq OMX Stockholm AB, Nasdaq OMX Tallinn AS, AB Nasdaq OMX Vilnius, Nasdaq OMX Clearing AB, Nasdaq OMX Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.


Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

   

Media Relations Contact:
Carl Norell
+46 8 405 6639
carl.norell@nasdaq.com

 


Attachments

Arcoma_Jonas Salomonson.jpg